LENZ Therapeutics Inc (LENZ)
Healthcare
Biotechnology
5.00 $
-5.8%
vs. previous close
Closing price · As of: 3. Aug 2026
LENZ Therapeutics Inc (LENZ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -69 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.0 | -8.7 | -53 | -88 | -60 | -59 | -69 | |
| – | 0.1 | 0.7 | 8.3 | 0.0 | 0.1 | -3.1 | |
| – | – | 0.2 | 0.7 | 1.3 | 6.4 | 13 | |
| 0.0 | 1.7 | -2.5 | -7.2 | 9.4 | -13 | 3.3 | |
| 0.0 | 1.5 | 5.7 | 6.6 | 0.0 | 0.5 | 0.8 | |
| – | -1.5 | -5.7 | -242 | -30 | -154 | -76 | |
| – | – | – | -0.1 | -0.1 | – | – | |
| – | 30 | 417 | 0.6 | 81 | 199 | 150 | |
| 0.0 | 20 | 357 | -329 | -9.3 | -15 | 4.9 | |
| 0.0 | -10 | -59 | -95 | -60 | -60 | -70 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.